Company ProfilePremium

Advik Capital Limited

Company Profile Analysis

Ticker: 539773.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Advik Capital Limited - Company showcase

Year Founded & Workforce

1985

10 Employees

Advik Capital Limited logo

Advik Capital Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Advik Capital Limited Overview

Advik Capital Limited is a New Delhi-based, BSE-listed, RBI-registered NBFC that has evolved from a dormant 1980s credit company and a brief diversification into electronics (LED signage via subsidiary Advik Optoelectronics) into a small lender and capital-markets investor. Its activities span inter-corporate loans, investment in listed and unlisted securities, and — through wholly-owned subsidiary Advikca Finvest Limited — securities dealing. Between FY2022 and FY2024 it reported large, low-margin trading turnover (₹604 cr in FY2023, ₹840 cr gross in FY2024) before restating to a lending-led revenue base of ~₹21–29 cr. Since late 2025 the company has been engulfed in governance and legal turmoil: a disputed ₹64 cr loan to Elitecon International, large provisions and quarterly losses, a hostile 23.46% shareholder suing to block its ₹100 cr rights issue, auditor qualification and resignation, and the July 2026 Enforcement Directorate arrest of promoter Vikas Garg. It is best characterised today as a distressed, governance-impaired micro-cap NBFC.


Company's own description. In its FY2025 (40th) Annual Report directors' report, the company states that it intends to keep concentrating on NBFC activities, specifically financing, inter-corporate investments and capital-market activities (Source: IIFL reproduction of Directors' Report FY2025). Its Q2 FY23 press release described it as headquartered in New Delhi and engaged primarily in financing, with the wholly owned subsidiary Advikca Finvest Limited set up to deal in capital-market instruments (Source: BSE press release, 19 Oct 2022). 2026 media releases describe it as an "emerging" NBFC focused on loans and ancillary financial services (Source: BSE media release, 8 Jan 2026; ScanX, Feb 2026). Screener's current description is that the company is primarily engaged in providing financial loans and allied services.

Reporting segments. Per aggregator classification of the latest annual report, the company operates through three segments: Securities/Share Division, Loan Division, and Others (Source: Simply Wall St).

Business model. Advik Capital earns income from three sources:

  1. Interest income on loans — chiefly inter-corporate deposits and term loans to corporate borrowers. The single largest disclosed exposure is a ₹64 cr loan to Elitecon International Limited (alleged loan agreement dated 12 August 2024), now subject to recovery and insolvency proceedings (Source: ScanX, Jan 2026; BSE media release, 16 Feb 2026).

  2. Gains/losses on securities — fair-value changes and trading in listed and unlisted shares, held in the parent and in Advikca Finvest Limited. This line has turned negative in recent quarters: "Other Revenue" was –₹4.23 cr on a TTM basis to December 2025 (Source: StockAnalysis), and reported revenue from operations was negative (–₹2.83 cr) in Q3 FY26 (Source: Multibagg/BSE results, Jan 2026).

  3. Trading turnover (historical) — in FY2022–FY2024 the consolidated group reported very large sales at near-zero margin (FY2023 revenue ₹604.29 cr against gross profit of ₹19.9 cr), consistent with commodity or securities trading booked gross.

Revenue model mix. Pure financial-services income (interest + investment gains). No product, subscription or licensing revenue. The electronics manufacturing revenue contributed by Advik Optoelectronics ended when that subsidiary was deconsolidated on 30 September 2024 (Source: Directors' Report FY2025).

Value-chain position. A balance-sheet lender funded by equity (repeated rights issues) and borrowings (interest expense of ₹10.8 cr in FY2025 — Source: StockAnalysis), lending to mid-sized corporate borrowers and taking principal positions in equities. It does not run retail lending, branch networks of scale, or fee-based advisory businesses of any disclosed size.

Customer types / end-markets. Corporate borrowers (inter-corporate loans) and capital markets (own-book investment). Retail customer base not disclosed. All operations are in India.

Independent characterisation. Advik Capital functions less as a conventional diversified NBFC than as a promoter-linked holding and treasury vehicle. Evidence: (i) four rights issues in roughly four years used to expand the equity base from ₹4.59 cr to ₹60.85 cr paid-up capital (Screener; ANI, Jun 2026); (ii) a concentrated ₹64 cr single-borrower exposure equal to a large share of its net worth; (iii) related-party, loan and tax issues flagged in the FY2026 auditor's qualified opinion (Screener announcement summary, Aug 2026); and (iv) allegations in the Fairplan derivative suit that ₹64 cr was routed through transactions involving Elitecon International, Global Tabac Legacy and Business Bay Agencies (ANI, 25 Jun 2026 — allegations not adjudicated). The business model's credibility is currently contingent on the outcome of litigation and regulatory investigations.

Strategy

Stated strategy (FY2025 Annual Report themes). The company's stated strategy is to keep focusing on NBFC activities — financing, inter-corporate investments and capital-market activities (Directors' Report FY2025). During the 2024 rights issue, management communicated an ambition to reach Systemically Important NBFC status by 2025 (DSIJ, Sep 2024). That target has not been achieved.

Initiatives announced in the last 24 months (Oct 2024 – Oct 2026).

ESG commitments: None disclosed.

Cost programmes: None disclosed.

Medium-term financial targets / guidance: None published, apart from the lapsed Systemically Important NBFC ambition.

Products & Services

No branded consumer products, platforms or technology offerings are disclosed.

Product Portfolio

SegmentOfferingDescriptionTarget customerLaunch / statusPricingSource

Loan Division

Inter-corporate loans / term loans

Secured and unsecured lending to companies; largest disclosed exposure ₹64 cr to Elitecon International

Mid-size corporates

Ongoing; core activity

Interest rate not publicly disclosed

ScanX; BSE media releases

Loan Division

Loans and ancillary financial services

General NBFC credit products described in 2026 releases

Corporates/individuals (not specified)

Ongoing

—

ScanX (Feb 2026)

Securities/Share Division

Proprietary equity investment (parent)

Investments in listed and unlisted shares

Own book

Ongoing; marked-to-market losses in FY26

—

Company PRs; StockAnalysis

Securities/Share Division

Advikca Finvest Limited

Dealing in shares, securities and related instruments; positioned for investment-advisory role

Own book / potential advisory clients

Incorporated 2022

—

Letter of Offer summary

Others / planned

Category II Alternative Investment Fund

Planned fund of up to ₹250 cr for healthcare, infrastructure and other growth sectors; intermediaries mandated

HNIs / institutional investors

Announced Nov 2023; SEBI registration/launch not found

Management fees not disclosed

BSE media release, 18 Nov 2023

Others (discontinued)

Electronics via Advik Optoelectronics

Escape signs, photoluminescent evacuation systems, LED and electronic LED signs, emergency lighting, safety clothing, traffic safety signs, luminaires

Commercial/industrial safety buyers

2013 – exit Sep 2024

—

InvestorGain/Letter of Offer

Others (historical)

Trading turnover

High-volume, low-margin trading booked gross in FY2022–FY2024 (nature of goods not specified in retrieved sources)

Counterparties not disclosed

Largely ceased after FY2024

—

Capital Market; StockAnalysis

“—” = not publicly disclosed.

Financial Narrative

Basis. Consolidated, INR crore, Ind AS, FY2021–FY2025 (latest five fiscal years with complete aggregator-verified data).

Primary sources. StockAnalysis income statement (INR millions converted to crore); Anand Rathi financial results page; Business Standard/Capital Market results notes; Directors' Report FY2025.

Income statement (consolidated)

Notes: FY2022 operating revenue 7.20 vs total revenue 46.47 reflects ₹39.27 cr of "other revenue" in StockAnalysis's classification; Anand Rathi shows FY2022 net sales of ₹46.46 cr. FY2024 originally reported sales of ₹839.59 cr (Capital Market, Apr 2024) — later series restate to ₹21.28 cr total revenue. FY2025 PAT shown as ₹8.23 cr (Anand Rathi) vs ₹8.40 cr attributable (Directors' Report) — the difference is minority interest/presentation.

Share count grew roughly 13× over the period (paid-up capital ₹4.59 cr → ₹60.85 cr), so per-share earnings have been heavily diluted relative to absolute profit. TTM EPS as of mid/late 2026 is –₹0.35 to –₹0.36 (Aaj Tak, Aug 2026; Investing.com, Sep 2026).

Dividends per share. Nil in every year; dividend yield 0.00% (Screener). RBI Act Section 45-IC requires transfer of at least 20% of net profit to a statutory reserve before any dividend (Directors' Report FY2025).

Margins (calculated from table 6.1)

Anand Rathi reports FY2025 PAT margin of 28.67% on its net-sales basis — consistent with the calculation above.

Revenue CAGR FY2021–FY2025 (calculated): 47% per year on the StockAnalysis total-revenue basis (₹6.25 cr → ₹29.30 cr). This figure is not meaningful as a growth indicator because of the FY2023 trading spike and the FY2024 restatement.

EBITDA. Depreciation is negligible (₹0–0.03 cr per quarter per Equitymaster). EBITDA is therefore approximately equal to operating income before interest. Formal EBITDA disclosure: not publicly disclosed.

Balance sheet

Only FY2022–FY2024 values are disclosed (InvestorGain summary of September 2024 Letter of Offer). The DSIJ article (Sep 2024) described the company as having total assets of about ₹200 cr.

Other balance-sheet items:

FY2026 and FY2027 year-to-date (quarterly, consolidated)

Sources: Q1FY26 total income ₹7.42 cr and Q4FY26 total income –₹7.45 cr (Kotak Neo, Aug 2026); Q2FY26 sales ₹5.67 cr and net profit ₹0.59 cr (Business Standard/Capital Market, Oct 2025); Q3FY26 revenue –₹2.83 cr and net loss ₹20.87 cr, including provisions of ₹18.77 cr (BSE results via Multibagg/ScanX, Jan 2026); Q1FY27 total income ₹4.15 cr and loss ₹1.19 cr (Kotak Neo); Q2FY27 sales ₹1.90 cr and net loss ₹6.93 cr (JM Financial/Capital Market, 15 Oct 2026).

Commentary on trends, inflections and drivers

FY2021–FY2022: dormant base. Revenue of ₹6 cr and profit below ₹0.5 cr, consistent with a shell-like listed NBFC before the Garg family consolidated control between October 2021 and April 2022.

FY2023–FY2024: turnover boom. Gross sales surged to ₹604 cr (FY2023) and ₹840 cr (FY2024 as originally reported) at gross margins of 1–3%. This was a scale-up of pass-through trading, funded by rights-issue equity and rising borrowings (interest expense rose from ₹0.20 cr in FY2022 to ₹7.54 cr in FY2024). Headline profit peaked at ₹9.3 cr in FY2023.

FY2025: reported peak of lending income. Operating revenue of ₹28.7 cr (now almost entirely interest and investment income, gross margin 99%) and PAT of ₹8.2–8.4 cr. However, interest costs climbed to ₹10.8 cr, so pre-tax margin compressed to 36.5%. Q4FY25 already showed a loss (–₹1.22 cr per IndMoney).

FY2026: collapse. Negative revenue in Q3 and Q4 reflects mark-to-market losses on securities. The ₹18.77 cr provision in Q3 is most plausibly linked to the disputed Elitecon exposure (inference; not explicitly confirmed in retrieved disclosures). The FY2026 audit carried qualifications on loans, related-party transactions and tax matters (Screener announcement summary), and the auditor resigned the next day.

FY2027 to date. Income has fallen to ₹2–4 cr per quarter and losses persist, with a ₹6.93 cr loss in Q2FY27 and negative operating margin (–11.58%). The core earnings engine is impaired: the main loan is non-performing and in litigation, the equity book is losing value, and new capital-raising is enjoined by court order.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipActivityStatusSource

Advik Capital Limited

Parent; listed NBFC

Lending, inter-corporate investments, capital-market activities

Active

Annual Report FY2025

Advikca Finvest Limited

Wholly owned subsidiary (100%; nominees hold 6 shares)

Dealing in shares and securities; investment activity

Active per FY2025 report

Directors' Report FY2025; Letter of Offer

Advik Optoelectronics Limited

Former subsidiary (57.99%)

LED signs, photoluminescent evacuation systems, emergency lighting, safety clothing, traffic signs

Ceased to be subsidiary 30 Sep 2024

Directors' Report FY2025

Advik Laboratories Limited

Promoter-group "sister" company (not a subsidiary)

Pharmaceuticals; separate rights issue also enjoined

Group concern

Punekar News; News24 (Jun 2026)

Segment Overview

SegmentContentsSource

Loan Division

Inter-corporate loans, term loans; interest income

Simply Wall St (segment names)

Securities/Share Division

Proprietary investment and dealing in equities (parent and Advikca Finvest)

Simply Wall St

Others

Residual activities; historically trading turnover and (to Sep 2024) electronics manufacturing

Simply Wall St

Results by Segment and Segment Assets & Liabilities

MetricFY2024FY2025

Standalone income from operations (INR Cr)

16.4423.07

Consolidated income from operations (INR Cr)

12.9228.72

Consolidated profit attributable to equity holders (INR Cr)

6.478.40

Income Statement

MetricFY2021FY2022FY2023FY2024FY2025

Total revenue (INR Cr, StockAnalysis basis)

6.2546.47604.3021.2829.30

Operating revenue (INR Cr)

5.777.20604.3012.9228.72

Cost of revenue (INR Cr)

4.4638.57584.401.190.28

Gross profit (INR Cr)

1.797.9019.9120.0929.02

Operating expenses (INR Cr)

1.507.173.783.736.47

Operating income before interest (INR Cr)

0.300.7316.1316.3622.55

Interest expense (INR Cr)

0.210.202.957.5410.80

Profit before tax (INR Cr)

0.100.6312.838.9810.69

Net profit (INR Cr)

0.080.489.356.368.23

Net profit attributable to owners (INR Cr)

0.080.489.286.478.40

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

28.617.03.394.499.0

Operating margin before interest (%)

4.81.62.776.977.0

Pre-tax margin (%)

1.61.42.142.236.5

Net margin (%)

1.31.01.529.928.1

Balance Sheet

MetricFY2021FY2022FY2023FY2024FY2025

Paid-up equity capital (INR Cr)

4.594.5922.0242.8260.85

Total assets (INR Cr, per Letter of Offer summary)

016.69142.56204.180

Financial Analysis

ItemLatest availableSource

Book value per share

₹2.35 (Sep–Oct 2026); ₹2.89 (early 2026, pre-loss); ₹2.62 (mid-2025); ₹1.85 (2024, pre-rights)

Screener snapshots

Implied net worth (calculated: BVPS × 60.85 cr shares)

≈ ₹143 cr (late 2026)

Calculated

Goodwill & intangibles

None disclosed

—

Working capital days (standalone)

0.95 (FY2025), –99.82 (FY2024), –1.41 (FY2023), 22.45 (FY2022)

Screener

Financial Analysis — Dividends paid

ItemDisclosure status

Dividends paid

Nil (FY2021–FY2025)

Equity raised

Rights issues: Mar 2022 (19:5), Sep 2023 (17:18), Oct 2024 (14:30 at ₹2.50; up to ₹49.95 cr). Paid-up capital rose from ₹4.59 cr to ₹60.85 cr in three years

Financial Analysis — ROE

RatioValuePeriodSource

ROE

4.78% (standalone); 5.93% (consolidated); 3-year average 9.24–11.0%

FY2025

Screener snapshots

ROE (latest)

–14.3%

TTM to Jun 2026

Screener (Oct 2026)

ROCE

8.31–8.42% (FY2025); –5.13% (latest)

FY2025; TTM

Screener

Interest coverage

Flagged "low" by Screener; calculated FY2025 operating income/interest = 2.1×

FY2025

Screener; calculated

Price/Book

0.43–0.45×

Aug–Oct 2026

Screener; Aaj Tak

Income Statement (Quarterly)

MetricQ1FY26Q2FY26Q3FY26Q4FY26Q1FY27Q2FY27

Total income / sales (INR Cr)

7.425.67-2.83-7.454.151.90

Net profit (INR Cr)

0.480.59-20.87-0.43-1.19-6.93

Revenue by Region

RegionFY2023FY2024FY2025

India revenue (INR Cr, consolidated total revenue)

604.3021.2829.30

Outside India revenue (INR Cr)

000

Change by Period

PeriodChangeAs ofSource

1 month

–0.76%

25 Dec 2025

Business Standard

3 months

–10.88%

25 Dec 2025

Business Standard

12 months

–41.26%

25 Dec 2025

Business Standard

3 years

–48.43%

25 Dec 2025

Business Standard

Valuation Snapshot

MultipleValueSource

P/E

Not meaningful (TTM EPS –₹0.35 to –₹0.36)

Aaj Tak; Investing.com

P/B

0.43–0.45×

Screener; Aaj Tak

Sector P/E reference

~20.5×

Aaj Tak

Capital Markets

ItemDetail

Analyst consensus

None. MarketsMojo algorithmic rating: "Strong Sell"

Dividend history

No dividends paid

Corporate actions

1:10 split (Dec 2017); rights issues Mar 2022 (19:5), Sep 2023 (17:18), Sep–Oct 2024 (14:30 at ₹2.50); proposed ₹100 cr rights (Apr 2026, enjoined)

Credit ratings (Moody's/S&P/Fitch or domestic)

None disclosed

Liquidity

Daily volumes typically 0.3–7 lakh shares (Aaj Tak; Investing.com; MarketsMojo)

Analyst Conclusions

Management guidance. None issued. Management's stated priorities are protecting shareholder interests, pursuing recovery from Elitecon and completing capital raising (ScanX, Jun 2026).

Consensus. No coverage.

Bull case

  1. Asset recovery. A successful NCLT/High Court outcome against Elitecon (₹71.15 cr claim) would bring in cash exceeding the current market cap (~₹62 cr) and allow write-back of the ₹18.77 cr provision.

  2. Deep discount to book. At ~0.45× book (≈₹143 cr implied net worth), even partial realisation of assets yields upside if remaining assets are genuine.

  3. Governance reset. A change of control — for example, Fairplan or another investor taking charge after the promoter's legal troubles — could lead to re-capitalisation under clean management.

Bear case

  1. Asset quality is unverifiable. The auditor qualified the FY2026 accounts on loans and related-party issues and then resigned, so reported book value may be overstated.

  2. Borrower disputes the debt. Elitecon contends the loan documents are forged, and SEBI has an interim order against Elitecon. Recovery could take years or fail.

  3. Promoter risk. The promoter is in PMLA proceedings with ≈₹940.77 cr of assets attached. The listed vehicle faces contagion, possible attachment of promoter shares, and regulatory scrutiny.

Catalysts and monitorables (next 12 months)

  • Appointment of a new statutory auditor and the nature of any further qualifications.

  • Delhi High Court / NCLT orders in the Elitecon matter.

  • Outcome of the Patiala House Court derivative suit and of the injunction on the rights issue.

  • Developments in the ED/PMLA case, including bail and any attachment of promoter shareholding.

  • Any RBI action on the NBFC registration.

  • Quarterly results (Q3 FY27 due by mid-February 2027), particularly further provisioning.

  • Stock-exchange surveillance measures (ASM/GSM).

Analyst verdict

Advik Capital Limited is no longer an investment case grounded in operating fundamentals; it is a special situation dominated by legal, governance and regulatory outcomes. Between FY2022 and FY2025 the company turned a dormant 1985 shell into a functioning NBFC. It raised equity through serial rights issues, scaled trading turnover to ₹600–840 cr, and by FY2025 generated ₹8 cr of profit on ₹29 cr of high-margin lending and investment income. That progress has unravelled within twelve months.

The concentrated ₹64 cr loan to Elitecon International — roughly 40% of current implied net worth — is disputed, with the borrower alleging forgery. A ₹18.77 cr provision in Q3 FY26 drove a ₹20.87 cr quarterly loss, and losses have continued into FY2027. The equity book has produced negative revenue. The FY2026 audit was qualified on loans, related-party and tax matters, and the auditor resigned the following day. A 23.46% shareholder has obtained a court injunction freezing the ₹100 cr rights issue on a prima facie case of mismanagement. The promoter, Vikas Garg, was arrested by the Enforcement Directorate on 14 July 2026 in a high-profile money-laundering case.

The 0.45× price-to-book multiple is not a margin of safety when the auditor has declined to vouch fully for the book. Positive optionality exists — successful recovery from Elitecon or a credible change of control could re-rate the stock sharply. But both outcomes depend on slow Indian judicial processes whose results are binary and outside management's control.

Verdict: High-risk, governance-impaired micro-cap. Institutional investors should regard the shares as uninvestable until three conditions are met:

  1. a new auditor issues an unqualified opinion;

  2. the Elitecon claim is resolved; and

  3. the promoter and control questions are settled.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure / appointmentBackgroundSource

Narendra Kumar Singhal

Whole-time Director (DIN 10800406); listed as CEO by aggregators

DIN series implies appointment c. 2024–2025

—

ScanX (Apr 2026); Simply Wall St

Vikas Garg

Promoter (former promoter-director)

Acquired control 2021–22

Promoter of Vikas Lifecare, Vikas Ecotech, Eraaya Lifespaces; chairman of Ebix Group; arrested by ED 14 Jul 2026

Exchange4media; TaxTMI/PTI

Seema Garg

Promoter-director (per 2024 SEBI order)

—

Promoter family

Moneylife

Sukriti Garg

Promoter-director (per 2024 SEBI order)

—

Promoter family

Moneylife

Mr.

Independent Director

Appointed Oct 2025

Over four decades in the Indian financial sector

ScanX (Oct 2025)

Nisha Mittal

Company Secretary & Compliance Officer

——

ScanX

——2,026—

ScanX headline

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContext

May 2025

New Company Secretary and statutory auditors appointed

Board meeting approving FY2025 results (Screener)

Oct 2025

Independent Director Puniani appointed

Governance strengthening (ScanX)

24 Jan 2026

Committees reconstituted

Same meeting as ₹20.87 cr Q3 loss

2026

CS resignation reported

ScanX headline

14 Jul 2026

Promoter arrested by ED

Mahadev/SkyExchange PMLA case

14 Aug 2026

Internal auditor appointed; FY26 audit qualified

Screener

15 Aug 2026

Statutory auditor KSMC & Associates resigns

Screener

Major Shareholders

HolderStakeDateSource

Fairplan Distributors Pvt. Ltd.

23.46% (14,27,77,126 shares)

27 Mar 2026

ScanX SAST disclosure

Promoter & promoter group (Garg family)

22.49%

Latest two quarters

Zerodha/Screener

Public / others

≈ 54% (calculated residual)

—

Calculated

Institutional (MF/FII)

Nil or negligible; not disclosed as material

—

Zerodha (no MF holding cited)

Competitive Landscape

Market Share by Competitor

CompetitorSegment overlapRevenue / market shareRelative positioningSource

Vibrant Global Capital

Investment & lending

—

Peer micro-cap

Business Standard peer list

Gowra Leasing & Finance

Lending / leasing

—

Peer micro-cap

Business Standard

Ramchandra Leasing & Finance

Lending

—

Peer micro-cap

Business Standard

Mukesh Babu Financial Services

Investment, lending

—

Peer micro-cap

Business Standard

WSFX Global Pay

Financial services (forex)

—

Adjacent

Business Standard

Bajaj Finance, Shriram Finance, Cholamandalam

Corporate/retail lending (scale benchmark)

Far larger (₹10,000s cr)

Not real competitors; define cost-of-funds benchmark

General industry knowledge

Recent Developments

The latter is the official arrest date per ED.

Company Snapshot

$3.4M

Revenue

10

Employees

1985

Founded

SWOT Analysis

Strengths

  • RBI NBFC licence — a regulated platform since the 2017 pivot (BSE media releases describe it as RBI-registered).
  • Low balance-sheet leverage historically — equity base expanded from ₹4.59 cr to ₹60.85 cr paid-up through three completed rights issues (Screener).
  • Proven ability to earn high-margin interest income at peak — FY2025 gross margin 99% and PAT ₹8.2–8.4 cr (StockAnalysis; Directors' Report).
  • Active legal enforcement — secured Delhi HC interim asset protection over Elitecon assets, extended to 7 Jul 2026 (BSE, Feb 2026).
  • SEBI adjudication clean order in the G G Engineering trading matter, 19 Dec 2025 (BSE filing).
  • Trading below book — P/B of 0.43–0.45× gives a theoretical value cushion if assets are realisable (Screener; Aaj Tak).

Weaknesses

  • Severe single-borrower concentration — ₹64 cr principal (₹71.15 cr with interest) to one disputed borrower (BSE media release).
  • Loss-making — Q3 FY26 loss ₹20.87 cr; Q2 FY27 loss ₹6.93 cr; ROE –14.3% (ScanX; JM Financial; Screener).
  • Qualified FY2026 audit on loans, related-party and tax issues, followed by auditor resignation (Screener).
  • Minimal organisation — 10 employees (Investing.com).
  • Low interest coverage — FY2025 operating income/interest ≈ 2.1× (calculated); flagged by Screener.
  • Volatile, low-quality revenue — negative revenue in two consecutive quarters (Q3–Q4 FY26) from investment losses (Kotak Neo; Multibagg).

Opportunities

  • Recovery of the Elitecon dues (₹71.15 cr) via NCLT/Delhi HC would restore over half of current market cap in cash (calculated vs ₹62 cr market cap).
  • Provision write-back if recovery succeeds (₹18.77 cr provided in Q3 FY26).
  • Resolution of the control contest — a credible new controlling shareholder (Fairplan holds 23.46%) could re-capitalise and reform governance.
  • Pending ₹100 cr rights issue if the injunction lifts.
  • Dormant AIF plan (₹250 cr target) could add fee income if revived under clean governance.
  • Approved increase in authorised capital (Jan 2026 postal ballot) provides headroom for re-capitalisation.

Threats

  • Promoter in ED custody with ≈₹940.77 cr of assets attached (ThePrint; The Hitavada).
  • Elitecon alleges loan documents are forged — risks invalidating Advik's claim (Value Research/BSE).
  • Possible RBI supervisory action given audit qualifications (inference; no RBI action disclosed).
  • Delisting/surveillance risk from auditor resignation and qualified opinions (inference from SEBI LODR norms).
  • Derivative suit alleging fraud and fund diversion — prima facie case accepted for interim relief (ANI).
  • Criminal and civil proceedings involving the promoter group — GTM Builders complaint, Advik Laboratories rights-issue injunction (Punekar News; News24).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025ED raids firms linked to promoter Vikas Garg (Mahadev probe) The WireEarly warning of promoter regulatory risk
23–24 May 2025FY2025 audited results (PAT ₹8.2–8.4 cr); new CS and auditors; postal ballot initiated ScreenerLast profitable full year
Aug 2025Q1 FY26 results — mixed: standalone profit dips, revenue surges ScanX—
Aug–Sep 2025Board proposes up to ₹300 cr raise and doubling of authorised capital ScanXAggressive expansion intent
26 Sep 202540th AGM ScanXCapital proposals tabled
15–16 Oct 2025Q2 FY26: net profit ₹0.59 cr; sales ₹5.67 cr (down 94% YoY) Business StandardReflects end of trading revenue
Oct 2025Independent Director Puniani appointed ScanXGovernance
Oct 2025 onwardFairplan begins open-market accumulation ScanXSets up control contest
–ED officials visit promoter's residence and an associated entity; company calls it a decade-old matter involving unrelated third parties ScanXPromoter risk
10 Dec 2025Delhi HC ex-parte interim order restraining Elitecon from creating third-party rights in its assets ScanXRecovery step
13 Dec 2025Disclosure of Elitecon proceedings to BSE BSE filing—
19–20 Dec 2025SEBI adjudication order (G G Engineering matter) — no adverse findings; company decries "misleading communications" BSE filing; ScanXRegulatory relief
2 Jan 2026Postal ballot: two ordinary resolutions passed, one special resolution rejected ScanXMinority pushback
5–8 Jan 2026Escalation of recovery
20 Jan 2026Website taken offline after unauthorised content detected ScanXCyber/operational risk
24 Jan 2026Q3 FY26: consolidated loss ₹20.87 cr; provisions ₹18.77 cr; negative revenue; committees reconstituted ScanX; MultibaggProfit collapse
7 Feb 2026Second cyber attack; website offline again ScanXCyber risk materialised
11–16 Feb 2026Delhi HC extends interim asset protection to 7 Jul 2026; Elitecon files vacation application claiming forged loan documents BSE media release; Value Research; ScanXContested recovery
27 Mar 2026Fairplan reaches 23.46%, exceeding promoter holding ScanXControl contest
30 Mar 2026SEBI ex-parte interim order against Elitecon ScanXBorrower credibility issue
3 Apr 2026Company confirms SEBI "large corporate" framework does not apply ScanXRoutine
9 Apr 2026Board approves ₹100 cr rights issue; shareholding concentration alert ANI; MultibaggFourth rights issue in four years
5 May 2026—
30 May – 2 Jun 2026Following a court order, company files criminal complaint against Fairplan and others ScanXEscalation
23 Jun 2026Discloses ED provisional attachment order against promoter ZerodhaPromoter asset risk
25 Jun 2026Patiala House Court restrains rights issue (derivative suit by Fairplan); returnable date 22 Aug 2026 ANI; AsianetCapital raising frozen
Early Jul 2026ED attaches ≈₹940.77 cr of assets of Garg, family and linked entities ThePrint; Telangana TodaySevere promoter risk
14 Jul 2026Vikas Garg arrested under PMLA; 10-day ED custody to 24 Jul; expelled from BJP 17 Jul The Hitavada; NewsBytesPromoter incapacitated
14–16 Aug 2026FY26 audited and Q1 FY27 results; qualified opinion citing loans, related-party and tax issues amid SEBI probe and ED attachment; internal auditor appointed Screener; Kotak NeoFinancial-reporting credibility impaired
15 Aug 2026Auditor KSMC & Associates resigns ScreenerRed flag
30 Sep 202641st AGM Screener—
15 Oct 2026Q2 FY27: net loss ₹6.93 cr; sales ₹1.90 cr (down 66%) JM Financial/Capital MarketContinued deterioration

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement: Revenue & Gross Profit: Total revenue rose from INR 62.5 Mn in FY2021 to INR 293 Mn in FY2025.
Advik Capital Limited — Income Statement: Revenue & Gross Profit
Series (INR Mn)FY2021FY2022FY2023FY2024FY2025
Total revenue62.5464.76,043212.8293
Operating revenue57.7726,043129.2287.2
Cost of revenue44.6385.75,84411.92.8
Gross profit17.979199.1200.9290.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. BSE filings and media releases (scrip 539773): Q1 FY21 results notice (Sep 2020); board meeting intimation (Aug 2019); Q2 FY23 press release (19 Oct 2022); AIF media release (18 Nov 2023); SEBI SCN disclosure (18 Feb 2025); SEBI adjudication disclosure (20 Dec 2025); NCLT media release (8 Jan 2026); Delhi HC media release (16 Feb 2026); Rights Issue Letter of Offer (Sep 2024) — bseindia.com / bsmedia.business-standard.com
  2. Screener.in — and /ADVIKCA/consolidated/ (screener.in)
  3. StockAnalysis (stockanalysis.com)
  4. Anand Rathi (anandrathi.com)
  5. IIFL — Directors' Report FY2025 (indiainfoline.com)
  6. Business Standard / Capital Market — Mar 2024 and Sep 2025 quarterly results notes; company profile page
  7. JM Financial / Capital Market — Q2 FY27 results (15 Oct 2026)
  8. Kotak Neo — Q1 FY27 results
  9. IndMoney; Fyers; Equitymaster; Torus Digital; Aaj Tak; Investing.com; Simply Wall St; Zerodha; MarketsMojo; Stockezee
  10. ScanX news archive (scanx.trade)
  11. Multibagg — Q3 FY26 and rights-issue articles
  12. ANI via Newswav / WebIndia123 / Asianet Newsable — Delhi court derivative-suit order (25 Jun 2026)
  13. Value Research — Elitecon BSE updates
  14. SEBI — Adjudication order, 20 Jun 2024; Moneylife and LiveLaw coverage
  15. ThePrint; The Wire; Telangana Today; Exchange4media; The Hitavada; TaxTMI (PTI); NewsBytes — ED arrest of Vikas Garg (Jul 2026)
  16. DSIJ; InvestorGain; Pocketful; Choice India; TradingQnA; IPO Central — rights-issue details
  17. Punekar News; News24 — Advik Laboratories injunction and promoter-group litigation

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.